Press Release

PhytoPharmacon LLC, a privately owned biopharmaceutical company, and BoProcess LLC, a privately owned biopharmaceutical company, announced on August 1, 2011 that the two companies have merged into one company PhytoPharmacon Inc. This merger will allow the combined company to strengthen the company’s intellectual property positioning.

Intellectual Properties:

Issued Patents:

  • US Patent: 7,795,306: Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-kappa.B (September 14, 2010)
  • US Patent: 7,323,476: Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases (January 29, 2008).
  • US Patent: 7226625: Identification of compositions, compositions and methods of treatment of obesity and overweight conditions (June 5, 2007).

Patents pending:

 Patents filed:

  • US Patents filed: Nutritional formula for managing Chronic Obstructive Pulmonary Disease (COPD) and lung health (June 13, 2011).
  • US Patent filed: Nutritional formula for managing Angina Pectoris (June 13, 2011).